Literature DB >> 3749925

Long-term management of polycythemia vera with hydroxyurea: a progress report.

M E Kaplan, K Mack, J D Goldberg, P B Donovan, P D Berk, L R Wasserman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3749925

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  14 in total

1.  Treatment of polycythemia vera by isovolemic large-volume erythrocytapheresis.

Authors:  U Kaboth; K W Rumpf; T Lipp; J Bigge; M Nauck; J H Beyer; W Seyde; W Kaboth
Journal:  Klin Wochenschr       Date:  1990-01-04

Review 2.  From leeches to personalized medicine: evolving concepts in the management of polycythemia vera.

Authors:  Alessandro M Vannucchi
Journal:  Haematologica       Date:  2016-11-24       Impact factor: 9.941

Review 3.  Hydroxyurea: The drug of choice for polycythemia vera and essential thrombocythemia.

Authors:  David Dingli; Ayalew Tefferi
Journal:  Curr Hematol Malig Rep       Date:  2006-06       Impact factor: 3.952

4.  Polycythemia vera. A clinical study of 141 patients.

Authors:  B Anger; U Haug; R Seidler; H Heimpel
Journal:  Blut       Date:  1989-12

5.  Cardiovascular Manifestations of Myeloproliferative Disorders: A Review of the Literature.

Authors:  Muhammad Wasif Saif; Umer Khan; Bernard R Greenberg
Journal:  Hosp Physician       Date:  1999-07

6.  Cardiac Complications of Myeloproliferative Disorders.

Authors:  Muhammad Wasif Saif; Umer Khan; Bernard R Greenberg
Journal:  Resid Staff Physician       Date:  2001-07

7.  Immunophenotypic characterisation of acute leukaemia after polycythemia vera.

Authors:  J M Hernández; A Orfao; M González; B Cuesta; M C López-Berges; M C Cañizo; J Ciudad; J F San Miguel
Journal:  J Clin Pathol       Date:  1993-07       Impact factor: 3.411

8.  [Clinical characterization of essential thrombocythemia in comparison with other myeloproliferative diseases and reactive thrombocytoses].

Authors:  M Jahn; B Zönnchen; W Köpcke; R Hehlmann
Journal:  Klin Wochenschr       Date:  1988-03-01

9.  Occlusion of the superior mesenteric artery in a patient with polycythemia vera: resolution with percutaneous transluminal angioplasty.

Authors:  X Bertrán; J Muchart; R Planas; M I Real; J M Ribera; E Cabré; M Menacho; M A Gassull
Journal:  Ann Hematol       Date:  1996-02       Impact factor: 3.673

Review 10.  Novel agents for the treatment of polycythemia vera: an insight into preclinical research and early phase clinical trials.

Authors:  Leslie Padrnos; Ruben Mesa
Journal:  Expert Opin Investig Drugs       Date:  2020-07-16       Impact factor: 6.206
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.